Publications by authors named "F O Bohmann"
Background: Advances in secondary stroke prevention, including direct oral anticoagulants (DOACs), dual antiplatelet therapies (DAPT), and cardiovascular risk management, have changed costs over the past decade. This study aimed to evaluate annual treatment costs and trends in drug-based secondary prophylaxis after ischemic strokes.
Methods: Annual treatment costs were evaluated using the net costs per defined daily dosage (DDD) of discharge medications for ischemic stroke patients treated in 2020 at the University Hospital Frankfurt, Germany.
Background: Data on impact of COVID-19 vaccination and outcomes of patients with COVID-19 and acute ischemic stroke undergoing mechanical thrombectomy are scarce. Addressing this subject, we report our multicenter experience.
Methods And Results: This was a retrospective analysis of patients with COVID-19 and known vaccination status treated with mechanical thrombectomy for acute ischemic stroke at 20 tertiary care centers between January 2020 and January 2023.
Article Synopsis
- - New guidelines on cerebral venous and dural sinus thrombosis (CVT) have emerged, focusing on risk factors, treatment options including direct oral anticoagulants, and interventional treatments, based on expert consensus from Germany, Austria, and Switzerland.
- - Key recommendations highlight that CVT may relate to severe thrombocytopenia post-SARS-CoV-2 vaccination, D-dimer testing is not advised for routine use, and thrombophilia screening should be considered under specific conditions.
- - Treatment recommendations suggest using low molecular weight heparin in the acute phase, with endovascular interventions for patients not responding adequately, and oral anticoagulation for 3 to 12 months afterward to reduce the risk of recurrence.
Rationale: Meta-analyses of case series of non-arteritic central retinal artery occlusion (CRAO) indicate beneficial effects of intravenous thrombolysis when initiated early after symptom onset. Randomized data are lacking to address this question.
Aims: The REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION) investigates intravenous alteplase within 4.
Background: The clinical course of ischemic and hemorrhagic strokes can be influenced by the coagulation status of individual patients. The prior use of antiplatelet therapy (APT) such as acetylsalicylic acid (ASA) or P2Y12-antagonists has been inconsistently described as possibly increasing the risk of hemorrhagic transformation or expansion. Since clinical studies describing prior use of antiplatelet medication are overwhelmingly lacking specific functional tests, we aimed to implement testing in routine stroke care.
View Article and Find Full Text PDF